Weight loss program with or without semaglutide for teens with obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial studies how the body adapts to weight loss in teens with obesity. You will either get a behavioral lifestyle program alone or with a weight loss medication called semaglutide.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 17 years old.
- You have been diagnosed with obesity (BMI at least 2 standard deviations above average for your age and sex).
- You are already enrolled in the Growing Health Weight Management or Next Step pediatric clinic and have at least one year left in the program.
- You are not using certain medications, such as antidepressants, anxiety drugs, or diabetes medications.
- You do not have type 1 or type 2 diabetes, pancreatitis, or a history of eating disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a GLP-1 medication (a drug that helps control appetite and blood sugar) combined with a lifestyle program for teens with severe obesity. The goal is to see if this approach can improve overall health and well-being.
This study tests whether a medication that helps with weight loss, called a GLP-1 agonist, can also change how the brain works. It is for teenagers (12-18) and adults (30-45) with obesity.
This trial studies whether semaglutide (a once-weekly injection) helps adolescents with a specific genetic form of obesity lose weight. It is for teens who are already being prescribed semaglutide as part of their regular care.
This study looks at how teenagers and young adults respond to weight-loss surgery (sleeve gastrectomy) and whether adding a medication called semaglutide can help improve weight loss. It has two parts: first observing how surgery affects you, then testing if semaglutide helps those who didn't lose enough weight after surgery.
This study tests whether semaglutide (a once-weekly injection that helps with weight loss) can help teenagers with autism who are obese. It will compare their results to similar teens who did not take the drug to see if it is safe and effective.
This trial tests if restarting semaglutide (a weekly injection for weight loss) soon after sleeve gastrectomy helps teens with severe obesity keep losing weight. It is for patients who were already taking semaglutide before their surgery.
Hear when a new Obesity (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.